Additionally, miR-6809-3p could counter the impacts on migration, proliferation, apoptosis, EMT, and the TGF-β1/SMAD2/3 pathway in GC cells caused by aberrant circMRPL35 and ZNF90 levels. Here, SMAD2 is linked to gastric cancer.